Redpoint Investment Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$738K Buy
9,159
+3,899
+74% +$330K 0.11% 238
2022
Q2
$392K Sell
5,260
-1,172
-18% -$107K 0.05% 432
2022
Q1
$823K Sell
6,432
-3,828
-37% -$419K 0.08% 291
2021
Q4
$1.38M Sell
10,260
-132
-1% -$19K 0.11% 216
2021
Q3
$1.42M Hold
10,392
0.12% 197
2021
Q2
$1.11M Hold
10,392
0.09% 261
2021
Q1
$934K Hold
10,392
0.08% 293
2020
Q4
$961K Buy
10,392
+180
+2% +$16.1K 0.1% 226
2020
Q3
$1.05M Sell
10,212
-11,736
-53% -$1.23M 0.11% 202
2020
Q2
$2.22M Buy
21,948
+2,144
+11% +$192K 0.12% 196
2020
Q1
$1.33M Buy
+19,804
New +$1.23M 0.08% 267
2019
Q3
Sell
-21,480
Closed -$805K 594
2019
Q2
$805K Hold
21,480
0.04% 399
2019
Q1
$640K Buy
+21,480
New +$755K 0.03% 422

Other funds holding DXCM

Redpoint Investment Management's DXCM Position: Q3 2022 in Review

Redpoint Investment Management increased its DexCom (DXCM) stake by 74% in Q3 2022, buying an estimated $330K and bringing the position to 9,159 shares worth $738K. The position accounts for 0.11% of the portfolio, ranked #238.

Redpoint Investment Management first reported a position in DXCM in Q1 2019 and has held it in 13 quarters since. The position peaked at $2.22M in Q2 2020. 794 funds tracked by Wall St. Rank hold DXCM as of Q3 2022.

  • Redpoint Investment Management held 9,159 shares of DexCom worth $738K as of Q3 2022.
  • Redpoint Investment Management bought 3,899 DexCom shares in Q3 2022, an estimated $330K.
  • DexCom made up 0.11% of Redpoint Investment Management's portfolio in Q3 2022, its #238 holding.
  • Redpoint Investment Management first reported a position in DexCom in Q1 2019 and has held it in 13 quarters since.
  • Redpoint Investment Management's DexCom position peaked at $2.22M in Q2 2020.
  • 794 funds tracked by Wall St. Rank held DexCom as of Q3 2022.

Based on Redpoint Investment Management's 13F filing for Q3 2022, filed 14 Oct 2022.